Blueprint Medicines Corp (BPMC) Insider Trading

Total insider buys:
  • $348,278.00
Total insider sells:
  • $152,874,979.57
Most recent insider trade:
  • March 28, 2024
Most active insider trader:
  • Jeffrey W Albers
Trader NameDateTitleAmountPriceTypeTotal Value
Nov. 15, 2021CEO30,000$114.50Sell$3,435,000.00
Nov. 3, 2021EVP5,000$110.56Sell$552,800.00
Oct. 15, 2021Insider729$102.66Sell$74,839.14
Oct. 5, 2021Insider3,241$98.18Sell$318,201.38
Sept. 23, 2021EVP25,000$108.85Sell$2,721,250.00
Sept. 23, 2021Insider600$110.00Sell$66,000.00
Aug. 19, 2021CEO25,000$92.68Sell$2,317,000.00
Aug. 17, 2021Insider1,350$91.93Sell$124,105.50
June 28, 2021COO1,000$90.24Sell$90,240.00
May 12, 2021CEO25,000$92.69Sell$2,317,250.00
Jan. 4, 2021Director758$112.15Sell$85,009.70
Dec. 24, 2020Director5,455$125.00Sell$681,875.00
Dec. 17, 2020Director10,909$117.82Sell$1,285,298.38
Dec. 1, 2020Director5,454$110.00Sell$599,940.00
Nov. 3, 2020Insider345$99.69Sell$34,393.05
Oct. 16, 2020COO13,334$101.23Sell$1,349,800.82
Oct. 7, 2020Director5,454$100.00Sell$545,400.00
Oct. 7, 2020CEO5,000$99.17Sell$495,850.00
Oct. 7, 2020Insider600$100.00Sell$60,000.00
Sept. 22, 2020COO3,143$85.49Sell$268,695.07
Sept. 22, 2020Director1,704$85.00Sell$144,840.00
Sept. 22, 2020Insider6,864$82.33Sell$565,113.12
Sept. 17, 2020Insider23,136$80.00Sell$1,850,880.00
Sept. 17, 2020Director500$80.00Sell$40,000.00
Aug. 17, 2020Insider700$75.00Sell$52,500.00
July 6, 2020Director26,007$80.45Sell$2,092,263.15
July 2, 2020Director4,125$80.16Sell$330,660.00
June 22, 2020Director13,017$80.29Sell$1,045,134.93
June 18, 2020Insider2,500$75.18Sell$187,950.00
June 9, 2020Insider700$75.00Sell$52,500.00
May 12, 2020CEO20,000$64.67Sell$1,293,400.00
March 23, 2020Insider1,214$52.49Sell$63,722.86
March 23, 2020CEO20,000$52.10Sell$1,042,000.00
Jan. 10, 2020COO7,763$85.16Sell$661,097.08
Jan. 10, 2020Director568$85.00Sell$48,280.00
Jan. 7, 2020Director1,705$80.59Sell$137,405.95
Dec. 19, 2019Insider4,600$79.00Sell$363,400.00
Dec. 16, 2019Insider415$75.00Sell$31,125.00
Dec. 4, 2019Insider192$77.25Sell$14,832.00
Nov. 18, 2019CEO8,256$75.42Sell$622,667.52
Nov. 8, 2019CEO11,744$74.56Sell$875,632.64
Oct. 17, 2019Insider415$75.00Sell$31,125.00
Sept. 16, 2019Insider415$78.14Sell$32,428.10
Aug. 21, 2019Insider10,000$80.07Sell$800,700.00
Aug. 19, 2019COO95$85.00Sell$8,075.00
Aug. 19, 2019CEO20,000$81.73Sell$1,634,600.00
Aug. 15, 2019Insider415$84.02Sell$34,868.30
Aug. 15, 2019Director10,000$82.40Sell$824,000.00
July 19, 2019Insider115$100.00Sell$11,500.00
July 16, 2019COO1,571$95.47Sell$149,983.37
  • Insiders are both buying and selling Blueprint Medicines Corp stock.

  • The insider traders at Blueprint Medicines Corp are: Jeffrey W Albers, Ariel Hurley, Kate Haviland, Daniel Lynch, Christopher K Murray, Marion Dorsch, George Demetri, Nicholas Lydon, Anthony L Boral, Tracey L Mccain, Fmr Llc, L. Becker Hewes, Christina Rossi, Christoph Lengauer, Michael Landsittel, Mark Alan Goldberg, Fouad Namouni, Debra Durso-Bumpus, Charles A Rowland Jr, Percy H Carter, Kevin P. Starr, Rock Ventures Ii L.P. Third, Lonnel Coats, Alexis Borisy, and Mark J Levin

  • The most active insider trader at Blueprint Medicines Corp is Jeffrey W Albers with 38 trades.

  • Rock Ventures Ii L.P. Third has sold the most Blueprint Medicines Corp stock with a total value of $70,560,000.00.

  • Mark Alan Goldberg has bought the most Blueprint Medicines Corp stock with a total value of $599,800.00.

  • The most recent insider trade for Blueprint Medicines Corp was on March 28, 2024.

  • The single biggest insider buy for Blueprint Medicines Corp was from Mark Alan Goldberg with a total value of $299,900.00 on March 3, 2022.

  • The single biggest insider sell for Blueprint Medicines Corp was from Rock Ventures Ii L.P. Third with a total value of $35,280,000.00 on Feb. 7, 2017.